Ovarian aging
Conditions
Interventions
1:TJAOA 101
1:TJAOA 102
Sponsors
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: (1) The age range of patient is 18-55 years old; (2) The diagnosis of women is DOR, POI, early menopause or menopausal syndrome and wish to improve ovarian function or menopausal syndrome; (3) Sign the informed consent form.
Exclusion criteria
Exclusion criteria: (1) The patient is known to be allergic or unsuitable for the Chinese herbal compound; (2) Women who are pregnant and lactating; (3) Patients of POI or DOR had been menopause for more than 1 year; (4) Abnormal uterine bleeding, except ovulation disorders; (5) Women who is taking hormone drugs and has stopped taking them within 3 months; (6) The diagnosis of women is endometriosis, myadenosis, submucosal fibroids or the size of non-submucosal fibroids is more than 4 cm; (7) The nature of pelvic mass is unknown; (8) The diagnosis of women is polycystic ovary syndrome, hyperprolactinemia, hyperandrogenemia, diabetes, thyroid and adrenal dysfunction and other endocrine diseases affecting ovulation; (9) Patients with serious primary diseases such as cardiovascular, liver, kidney, lung, biliary, hematopoietic system (Hb<90g/L) and malignant tumor, and psychiatric patients; (10) Patients who are participating in other clinical trials or have participated in other clinical trials within the last month; (11) Patients who are unsuitable for the study evaluated by the investigator.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment; | — |
Primary
| Measure | Time frame |
|---|---|
| Menstruation recovery rate;AMH;Patient's life quality;AFC;Sex hormone; | — |
Countries
China
Contacts
Public ContactShixuan Wang
Outcome results
None listed